最新ニュース WK Kellogg (NYSE:KLG) 株価情報

WK Kellogg

WK Kellogg is the second-largest cereal manufacturer in North America. Its cereal brands include Special K, Frosted Flakes, Raisin Bran, Froot Loops, Frosted Mini-Wheats, Kashi, Corn Flakes, Rice Krispies, Apple Jacks, and Bear Naked. The company was spun off from the former Kellogg business, now known as Kellanova, where the former firm's global snacks portfolio and international cereal brands are now housed. WK Kellogg, which began trading independently in October 2023, generates the bulk of its sales (about 88% of its fiscal 2024 base) in the US.

WK Kellogg Co

Kalo Gold Corp

KLEGG ELECTRONICS INC by Klegg Electronics, Inc.

Klegg Electronics Inc

KERRY LOGISTICS UNSP/ADR by Kerry Logistics Network Ltd

KLN Logistics Group Ltd

Asure Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASUR#NASDAQ">ASUR</a>) reported quarterly earnings of $0.19 per share which beat the analyst consensus estimate of $0.18 by 5.56 percent. This is a 13.64 percent decrease over earnings of $0.22 per share from the same period last year. The company reported quarterly sales of $34.85 million which beat the analyst consensus estimate of $34.20 million by 1.90 percent. This is a 10.12 percent increase over sales of $31.65 million the same period last year.

Earnings

Earnings Beats

News

ASUR

CORRECTION: Asure Software Q1 Adj. EPS $0.19 Beats $0.18 Estimate, Sales $34.85M Beat $34.20M Estimate

Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>) has outperformed the market over the past 10 years by 1.78% on an annualized basis producing an average annual return of 12.16%. Currently, Morgan Stanley has a market capitalization of $187.23 billion. 
Buying $1000 In MS: If an investor had bought $1000 of MS stock 10 years ago, it would be worth $3,117.76 today based on a price of $116.51 for MS at the time of writing.
<h3>Morgan Stanley's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746138611_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today

Sun Country Airlines (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNCY#NASDAQ">SNCY</a>) sees Q2 sales of $250.000 million-$260.000 million vs $266.61 million analyst estimate.

Guidance

SNCY

Sun Country Airlines Sees Q2 Sales $250.000M-$260.000M vs $266.61M Est

NPK International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NPKI#NYSE">NPKI</a>) sees FY2025 sales of $240.000 million-$252.000 million vs $238.13 million analyst estimate.

NPKI

NPK International Sees FY2025 Sales $240.000M-$252.000M vs $238.13M Est

Barclays analyst Jeffrey Bernstein maintains Yum Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YUM#NYSE">YUM</a>) with a Overweight and raises the price target from $163 to $167.

Price Target

Analyst Ratings

Barclays Maintains Overweight on Yum Brands, Raises Price Target to $167

Universal Display (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLED#NASDAQ">OLED</a>) reported quarterly earnings of $1.35 per share which beat the analyst consensus estimate of $1.07 by 26.17 percent. This is a 13.45 percent increase over earnings of $1.19 per share from the same period last year. The company reported quarterly sales of $166.30 million which beat the analyst consensus estimate of $156.08 million by 6.55 percent. This is a 0.63 percent increase over sales of $165.26 million the same period last year.

OLED

CORRECTION: Universal Display Q1 EPS $1.35 Beats $1.07 Estimate, Sales $166.30M Beat $156.08M Estimate

Barclays analyst Peter Lawson maintains Bicycle Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCYC#NASDAQ">BCYC</a>) with a Overweight and lowers the price target from $40 to $15.

BCYC

Barclays Maintains Overweight on Bicycle Therapeutics, Lowers Price Target to $15

Equinix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EQIX#NASDAQ">EQIX</a>) has outperformed the market over the past 20 years by 9.55% on an annualized basis producing an average annual return of 17.69%. Currently, Equinix has a market capitalization of $83.90 billion. 
Buying $100 In EQIX: If an investor had bought $100 of EQIX stock 20 years ago, it would be worth $2,530.00 today based on a price of $861.97 for EQIX at the time of writing.
<h3>Equinix's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746137714_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

EQIX

Here's How Much You Would Have Made Owning Equinix Stock In The Last 20 Years

Loop Capital analyst Laura Champine maintains Norwegian Cruise Line (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NCLH#NYSE">NCLH</a>) with a Buy and lowers the price target from $25 to $24.

NCLH

Loop Capital Maintains Buy on Norwegian Cruise Line, Lowers Price Target to $24

Loop Capital analyst Gary Mobley maintains Qualcomm (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>) with a Hold and lowers the price target from $180 to $155.

QCOM

Loop Capital Maintains Hold on Qualcomm, Lowers Price Target to $155

Loop Capital analyst Laura Champine maintains Etsy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ETSY#NASDAQ">ETSY</a>) with a Sell and lowers the price target from $40 to $37.

ETSY

Loop Capital Maintains Sell on Etsy, Lowers Price Target to $37

Maplebear Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CART#NASDAQ">CART</a>) reported first-quarter financial results Thursday after the market close. Shares are moving higher, despite slightly missing analyst estimates. Here&#8217;s a rundown <a href="https://www.benzinga.com/pressreleases/25/05/n45149977/instacart-announces-first-quarter-2025-financial-results">of the print.</a>
<ul>
<li>Q1 Revenue: $897 million, versus <a href="https://www.benzinga.com/calendars/earnings">estimates</a> of $898.02 million</li>
</ul>
<ul>
<li>Q1 EPS: 37 cents, versus estimates of 38 cents </li>
</ul>
The delivery aggregator said orders increased 14% year-over-year to 83.2 million in the first quarter as total revenue jumped 9%. Gross transaction value climbed 10% year-over-year to $9.12 billion. 
&#8220;This performance reflects the critical role we play in helping families fill their fridges and pantries, as well as the benefit of our growth initiatives, which are giving consumers even more reasons to turn to Instacart,&#8221; the company said in a letter to shareholders.
See Also: <a href="https://www.benzinga.com/news/earnings/25/05/45152693/roku-q1-double-beat-adds-new-streaming-platform-shares-drop-on-cautious-guidance-tariff-risks">Roku Q1 Double Beat, Adds New Streaming Platform — Shares Drop On Cautious Guidance, Tariff Risks</a>
Guidance: The Instacart parent company guided for a second-quarter gross transaction value of $8.85 billion to $9 billion. The company also anticipates second-quarter Adjusted EBITDA of $240 million to $250 million versus $244 million in the first quarter.
&#8220;Over the past 13 years, we've consistently shown our ability to grow even during periods of macro uncertainty and economic challenges. Groceries aren't discretionary — they're essential — and by helping families save time, money, and effort every day, we're expanding the market, deepening our role in customers' lives, and strengthening our value to our retail and brand partners,&#8221; the company said. 
CART Price Action: <a href="http://benzinga.com/quote/cart">Maplebear shares</a> were up 3.40% after hours, trading at $41.15 at the time of publication on Thursday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: Shutterstock

After-Hours Center

Movers

CART

Instacart Q1 Earnings: Revenue, EPS Come Up Short Despite 14% Order Growth — 'Groceries Aren't Discretionary — They're Essential'

Lake Street analyst Eric Martinuzzi maintains Extreme Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXTR#NASDAQ">EXTR</a>) with a Hold and lowers the price target from $16 to $15.

EXTR

Lake Street Maintains Hold on Extreme Networks, Lowers Price Target to $15

Lake Street analyst Jacob Stephan maintains Alkami Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALKT#NASDAQ">ALKT</a>) with a Buy and lowers the price target from $47 to $41.

ALKT

Lake Street Maintains Buy on Alkami Technology, Lowers Price Target to $41

AptarGroup (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATR#NYSE">ATR</a>) reported quarterly earnings of $1.20 per share which beat the analyst consensus estimate of $1.16 by 3.45 percent. This is a 1.64 percent decrease over earnings of $1.22 per share from the same period last year. The company reported quarterly sales of $887.30 million which missed the analyst consensus estimate of $898.63 million by 1.26 percent. This is a 3.07 percent decrease over sales of $915.45 million the same period last year.

Earnings Misses

AptarGroup Q1 Adj. EPS $1.20 Beats $1.16 Estimate, Sales $887.30M Miss $898.63M Estimate

William Blair analyst Brian Weinstein downgrades Becton Dickinson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BDX#NYSE">BDX</a>) from Outperform to Market Perform.

Downgrades

William Blair Downgrades Becton Dickinson to Market Perform

Talen Energy Corporation ("Talen") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLN#NASDAQ">TLN</a>) announced today that the Federal Energy Regulatory Commission (the "FERC") has approved the terms under which Talen will operate units at its Brandon Shores and H.A. Wagner power plants until May 31, 2029, beyond their scheduled May 31, 2025 retirement dates.
Talen, PJM Interconnection, L.L.C. ("PJM"), and a broad coalition of the Maryland Public Service Commission, Maryland customers, and electric utilities reached agreement in January on the "reliability-must-run" or "RMR" agreement approved today by FERC. Under the RMR agreement, Brandon Shores Units 1 and 2 and H.A. Wagner Units 3 and 4 will remain in service and provide power necessary to maintain grid and transmission reliability in and around the City of Baltimore until transmission upgrades to provide reliable power to the area from other sources are complete.&nbsp;&nbsp;

Talen Energy Announces The Federal Energy Regulatory Commission Has Approved The Terms Under Which Talen Will Operate Units At Its Brandon Shores And H.A. Wagner Power Plants Until May 31, 2029, Beyond Their Scheduled May 31, 2025 Retirement Dates.

Across the recent three months, 12 analysts have shared their insights on Humana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUM#NYSE">HUM</a>), expressing a variety of opinions spanning from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">8</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $297.75, a high estimate of $326.00, and a low estimate of $256.00. Observing a 5.28% increase, the current average has risen from the previous average price target of $282.82. 
<img src="https://www.benzinga.com/files/images/story/2025/1746136884_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
The standing of Humana among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Sarah James</td>
<td>Cantor Fitzgerald</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$290.00</td>
<td>$290.00</td>
</tr>
<tr>
<td>Michael Wiederhorn</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$310.00</td>
<td>$300.00</td>
</tr>
<tr>
<td>Michael Ha</td>
<td>Baird</td>
<td>Raises</td>
<td>Neutral</td>
<td>$300.00</td>
<td>$270.00</td>
</tr>
<tr>
<td>Andrew Mok</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$322.00</td>
<td>$270.00</td>
</tr>
<tr>
<td>David Macdonald</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Hold</td>
<td>$325.00</td>
<td>$290.00</td>
</tr>
<tr>
<td>Jason Cassorla</td>
<td>Guggenheim</td>
<td>Announces</td>
<td>Buy</td>
<td>$326.00</td>
<td>-</td>
</tr>
<tr>
<td>Ann Hynes</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Outperform</td>
<td>$316.00</td>
<td>$305.00</td>
</tr>
<tr>
<td>Lisa Gill</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$256.00</td>
<td>$257.00</td>
</tr>
<tr>
<td>Andrew Mok</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$270.00</td>
<td>$255.00</td>
</tr>
<tr>
<td>Ben Hendrix</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$283.00</td>
<td>$283.00</td>
</tr>
<tr>
<td>Sarah James</td>
<td>Cantor Fitzgerald</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$290.00</td>
<td>$290.00</td>
</tr>
<tr>
<td>Erin Wright</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$285.00</td>
<td>$301.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Humana. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Humana compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Capture valuable insights into Humana's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/HUM/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Humana analyst ratings.</a>
<h2>Discovering Humana: A Closer Look</h2>
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
<h3>A Deep Dive into Humana's Financials</h3>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Over the 3M period, Humana showcased positive performance, achieving a revenue growth rate of 10.4% as of 31 December, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector.
Net Margin: Humana's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of -2.37%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Humana's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of -4.08%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Humana's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of -1.44%, the company may face hurdles in achieving optimal financial performance.
Debt Management: Humana's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.72.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

What Analysts Are Saying About Humana Stock

Cognex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGNX#NASDAQ">CGNX</a>) has been analyzed by 9 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $38.89, a high estimate of $56.00, and a low estimate of $26.00. A decline of 12.27% from the prior average price target is evident in the current average. 
<img src="https://www.benzinga.com/files/images/story/2025/1746136876_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
The analysis of recent analyst actions sheds light on the perception of Cognex by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>James Ricchiuti</td>
<td>Needham</td>
<td>Lowers</td>
<td>Buy</td>
<td>$33.00</td>
<td>$41.00</td>
</tr>
<tr>
<td>Piyush Avasthy</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$26.00</td>
<td>$37.00</td>
</tr>
<tr>
<td>Jamie Cook</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$29.00</td>
<td>$37.00</td>
</tr>
<tr>
<td>Tommy Moll</td>
<td>Stephens &amp; Co.</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$55.00</td>
<td>$55.00</td>
</tr>
<tr>
<td>Joe Ritchie</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Sell</td>
<td>$35.00</td>
<td>$39.00</td>
</tr>
<tr>
<td>Damian Karas</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$56.00</td>
<td>$58.00</td>
</tr>
<tr>
<td>Richard Eastman</td>
<td>Baird</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$38.00</td>
<td>$42.00</td>
</tr>
<tr>
<td>Jamie Cook</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$37.00</td>
<td>$43.00</td>
</tr>
<tr>
<td>James Ricchiuti</td>
<td>Needham</td>
<td>Lowers</td>
<td>Buy</td>
<td>$41.00</td>
<td>$47.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Cognex. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Cognex compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Cognex's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Cognex's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/CGNX/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Cognex analyst ratings.</a>
<h2>Delving into Cognex's Background</h2>
Cognex Corp provides machine vision products that help automate manufacturing processes. The firm's products include vision software, vision systems, vision sensors, and ID products. Vision software combines vision tools with a customer's cameras and peripheral equipment and can help with several vision tasks, including part location, identification, measurement, and robotic guidance. Vision systems combine a camera, processor, and vision software into a single package. Vision sensors deliver simple, low-cost solutions for common vision applications, such as checking the size of parts. ID products read codes that have been applied to items during the manufacturing process. Cognex generates the maximum proportion of its sales in the United States and Europe.
<h3>Financial Milestones: Cognex's Journey</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Growth: Over the 3M period, Cognex showcased positive performance, achieving a revenue growth rate of 16.79% as of 31 December, 2024. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Information Technology sector.
Net Margin: Cognex's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 12.34% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Cognex's ROE stands out, surpassing industry averages. With an impressive ROE of 1.84%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Cognex's ROA stands out, surpassing industry averages. With an impressive ROA of 1.4%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Cognex's debt-to-equity ratio is below the industry average at 0.05, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>How Are Analyst Ratings Determined?</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CGNX

A Glimpse Into The Expert Outlook On Cognex Through 9 Analysts

Providing a diverse range of perspectives from bullish to bearish, 10 analysts have published ratings on Waste Management (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WM#NYSE">WM</a>) in the last three months.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $251.7, with a high estimate of $271.00 and a low estimate of $229.00. This current average reflects an increase of 5.93% from the previous average price target of $237.60. 
<img src="https://www.benzinga.com/files/images/story/2025/1746136867_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
A comprehensive examination of how financial experts perceive Waste Management is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Bryan Burgmeier</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$271.00</td>
<td>$260.00</td>
</tr>
<tr>
<td>Sabahat Khan</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$229.00</td>
<td>$227.00</td>
</tr>
<tr>
<td>David Manthey</td>
<td>Baird</td>
<td>Raises</td>
<td>Neutral</td>
<td>$245.00</td>
<td>$235.00</td>
</tr>
<tr>
<td>Jon Windham</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$250.00</td>
<td>$240.00</td>
</tr>
<tr>
<td>Wesley Brooks</td>
<td>HSBC</td>
<td>Raises</td>
<td>Buy</td>
<td>$265.00</td>
<td>$210.00</td>
</tr>
<tr>
<td>Jon Windham</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$240.00</td>
<td>$230.00</td>
</tr>
<tr>
<td>Konark Gupta</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Outperform</td>
<td>$260.00</td>
<td>$255.00</td>
</tr>
<tr>
<td>Kevin Chiang</td>
<td>CIBC</td>
<td>Raises</td>
<td>Neutral</td>
<td>$247.00</td>
<td>$227.00</td>
</tr>
<tr>
<td>Bryan Burgmeier</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$255.00</td>
<td>$242.00</td>
</tr>
<tr>
<td>Konark Gupta</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Outperform</td>
<td>$255.00</td>
<td>$250.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Waste Management. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Waste Management compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Waste Management's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
To gain a panoramic view of Waste Management's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/WM/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Waste Management analyst ratings.</a>
<h2>All You Need to Know About Waste Management</h2>
WM ranks as the largest integrated provider of traditional solid waste services in the United States, operating 263 active landfills and about 332 transfer stations. The company serves residential, commercial, industrial, and medical end markets and is also a leading recycler in North America.
<h3>Key Indicators: Waste Management's Financial Health</h3>
Market Capitalization Analysis: The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.
Revenue Growth: Over the 3M period, Waste Management showcased positive performance, achieving a revenue growth rate of 2.12% as of 31 March, 2025. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Industrials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Waste Management's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 10.58% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Waste Management's ROE excels beyond industry benchmarks, reaching 7.54%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Waste Management's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.43% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Waste Management's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 2.76.
<h2>How Are Analyst Ratings Determined?</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Expert Outlook: Waste Management Through The Eyes Of 10 Analysts

Press Releases

WK Kellogg Co Announces Third Quarter Financial Results and Raises 2024 Adjusted EBITDA Guidance

WK Kellogg Co to Participate in Morgan Stanley Global Consumer & Retail Conference

WK Kellogg Co to Host Conference Call on February 11

WK Kellogg Co to Webcast Presentation at CAGNY Conference on Feb. 19, 2025

Dividends

WK Kellogg Co Announces Dividend Increase

WK Kellogg Co Announces Fourth Quarter and Full Year 2024 Financial Results; Provides 2025 Financial Outlook

Spin-Offs: Potential Catalysts for Big Gains

WK Kellogg Co to Host Annual Shareholder Meeting

WK Kellogg Co to Report First Quarter 2025 Results May 6

WK Kellogg Co Declares Quarterly Dividend of $0.165 per Share

OSTX

Adecoagro

Mission Produce

B&G Foods

Cal-Maine Foods

Calavo Growers

Dole

Flowers Foods

Freshpet

John B. Sanfilippo & Son, Inc. - Common Stock

John B Sanfilippo & Son

J&J Snack Foods

Lancaster Colony Corporation - Common Stock

Lancaster Colony

Lamb Weston Hldgs

Lifeway Foods

Nomad Foods

Post Holdings

Seaboard

Seneca Foods Corp. - Class A Common Stock

Seneca Foods

Seneca Foods Corp. - Class B Common Stock

The Simply Good Foods Company - Common Stock

Simply Good Foods

Treehouse Foods

Tootsie Roll Industries, Inc. Common Stock

Comments

WK Kellogg

ニュース

最新ニュース WK Kellogg (NYSE:KLG) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル